Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine

OBJECTIVES: The atypical antipsychotics, risperidone, olanzapine, and quetiapine, have been approved by the U.S. Food and Drug Administration for treatment of mania associated with bipolar disorder. Information on the relative mental health resource use of these therapies is helpful to pharmacy mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianfrancesco, Frank, Pesa, Jacqueline, Wang, Ruey-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437411/
https://www.ncbi.nlm.nih.gov/pubmed/15804206
http://dx.doi.org/10.18553/jmcp.2005.11.3.220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437411/
https://www.ncbi.nlm.nih.gov/pubmed/15804206
http://dx.doi.org/10.18553/jmcp.2005.11.3.220

Ejemplares similares